Package 69238-2090-4

Brand: famotidine

Generic: famotidine
NDC Package

Package Facts

Identity

Package NDC 69238-2090-4
Digits Only 6923820904
Product NDC 69238-2090
Description

50 mL in 1 BOTTLE (69238-2090-4)

Marketing

Marketing Status
Marketed Since 2022-08-05
Brand famotidine
Generic famotidine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ddc06a12-1bc6-4006-ba9c-ed389599b532", "openfda": {"nui": ["N0000000151", "N0000175784"], "upc": ["0369238209044"], "unii": ["5QZO15J2Z8"], "rxcui": ["310274"], "spl_set_id": ["bb602b05-0ce6-4029-bd6e-291076e64efb"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 BOTTLE (69238-2090-4)", "package_ndc": "69238-2090-4", "marketing_start_date": "20220805"}], "brand_name": "Famotidine", "product_id": "69238-2090_ddc06a12-1bc6-4006-ba9c-ed389599b532", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "69238-2090", "generic_name": "Famotidine", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "40 mg/5mL"}], "application_number": "ANDA216427", "marketing_category": "ANDA", "marketing_start_date": "20220805", "listing_expiration_date": "20261231"}